These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3020591)

  • 1. The binding of 6-oxo-prostaglandin E1 to platelet prostanoid receptors.
    Jaschonek K; Renn W; Weisenberger H
    Prostaglandins Leukot Med; 1986 Sep; 24(1):79-86. PubMed ID: 3020591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel mechanism of heterologous desensitization of adenylate cyclase: prostaglandins bind with different affinities to both stimulatory and inhibitory receptors on platelets.
    Ashby B
    Mol Pharmacol; 1990 Jul; 38(1):46-53. PubMed ID: 1695318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refractoriness of platelets to prostaglandins after infusion in rabbits.
    Bertelé V; Stemerman M; Schafer A; Adelman B; Smith M; Fuhro R; Salzman E
    J Lab Clin Med; 1985 Nov; 106(5):551-61. PubMed ID: 2997353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of stable prostaglandins to investigate prostacyclin (PGI2)-binding sites and PGI2-sensitive adenylate cyclase in human platelet membranes.
    Lombroso M; Nicosia S; Paoletti R; Whittle BJ; Moncada S; Vane JR
    Prostaglandins; 1984 Feb; 27(2):321-33. PubMed ID: 6326201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desensitization of prostaglandin-activated platelet adenylate cyclase.
    Cooper B; Schafer AI; Puchalsky D; Handin RI
    Prostaglandins; 1979 Apr; 17(4):561-71. PubMed ID: 461820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of prostaglandin E1-induced activation of adenylate cyclase in human blood platelet membrane.
    Kahn NN; Sinha AK
    Biochim Biophys Acta; 1988 Oct; 972(1):45-53. PubMed ID: 2902882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for distinct prostaglandin I2 and D2 receptors in human platelets.
    Miller OV; Gorman RR
    J Pharmacol Exp Ther; 1979 Jul; 210(1):134-40. PubMed ID: 221643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interrelationships between PGE1 and PGI2 binding and stimulation of adenylate cyclase.
    Garrity MJ; Westcott KR; Eggerman TL; Andersen NH; Storm DR; Robertson RP
    Am J Physiol; 1983 Apr; 244(4):E367-72. PubMed ID: 6132556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stable 9 beta- or 11 alpha-halogen-15-cyclohexyl-prostaglandins with high affinity to the PGD2-receptor.
    Thierauch KH; Stürzebecher CS; Schillinger E; Rehwinkel H; Radüchel B; Skuballa W; Vorbrüggen H
    Prostaglandins; 1988 Jun; 35(6):855-68. PubMed ID: 2847246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Competitive antagonism at thromboxane receptors in human platelets.
    Armstrong RA; Jones RL; Peesapati V; Will SG; Wilson NH
    Br J Pharmacol; 1985 Mar; 84(3):595-607. PubMed ID: 2580580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta 2-adrenergic regulation of prostaglandin D2 receptor in rabbit platelets.
    Hanasaki K; Mizuno Y; Ikeda M; Shimonishi M; Yoshimura S; Tomita K; Ichikawa A
    Biochim Biophys Acta; 1987 Feb; 927(2):261-8. PubMed ID: 2880608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of activation of protein kinase C on the agonist-induced stimulation and inhibition of cyclic AMP formation in intact human platelets.
    Williams KA; Murphy W; Haslam RJ
    Biochem J; 1987 May; 243(3):667-78. PubMed ID: 2444206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of protein kinase C activation on human platelet cyclic AMP metabolism.
    Bushfield M; Hopple SL; Gibson IF; Murdoch FA; MacIntyre DE
    FEBS Lett; 1987 Oct; 222(2):299-304. PubMed ID: 2820806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (5Z)-carbacyclin discriminates between prostacyclin-receptors coupled to adenylate cyclase in vascular smooth muscle and platelets.
    Corsini A; Folco GC; Fumagalli R; Nicosia S; Noe MA; Oliva D
    Br J Pharmacol; 1987 Jan; 90(1):255-61. PubMed ID: 3545351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding to prostaglandin (PG) receptors and activation of adenyl cyclase by 20-isopropylidene-PGS in rabbit platelet membranes.
    Ushiyama S; Handa S; Yamazaki M
    Prostaglandins; 1988 Oct; 36(4):477-89. PubMed ID: 2853419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental Differences in Platelet Inhibition Response to Prostaglandin E1.
    Palma-Barqueros V; Torregrosa JM; Caparrós-Pérez E; Mota-Pérez N; Bohdan N; Llanos MDC; Begonja AJ; Sola-Visner M; Vicente V; Teruel-Montoya R; Rivera J; Ferrer-Marín F
    Neonatology; 2020; 117(1):15-23. PubMed ID: 31786577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin endoperoxide analogues which are both thromboxane receptor antagonists and prostacyclin mimetics.
    Armstrong RA; Jones RL; MacDermot J; Wilson NH
    Br J Pharmacol; 1986 Mar; 87(3):543-51. PubMed ID: 3026540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of prostaglandin and thromboxane receptors expressed on a megakaryoblastic leukemia cell line, MEG-01s.
    Watanabe T; Yatomi Y; Sunaga S; Miki I; Ishii A; Nakao A; Higashihara M; Seyama Y; Ogura M; Saito H
    Blood; 1991 Nov; 78(9):2328-36. PubMed ID: 1718495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
    Maurice DH; Haslam RJ
    Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of prostaglandin (PG)-binding sites expressed on human basophils. Evidence for a prostaglandin E1, I2, and a D2 receptor.
    Virgolini I; Li S; Sillaber C; Majdic O; Sinzinger H; Lechner K; Bettelheim P; Valent P
    J Biol Chem; 1992 Jun; 267(18):12700-8. PubMed ID: 1377673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.